July 1 (Reuters) - Moderna Inc (MRNA.O) said on Thursday that contract manufacturer Recipharm had begun making the company's COVID-19 vaccine at its manufacturing site in France after gaining approval from Europe's drugs regulator.
Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel
Our Standards: The Thomson Reuters Trust Principles.